Kathelijne C J M Kraal

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 3

Top Topics

Combination Therapy

Patient Reported Outcomes

Immune Response

Liver Metastases

Top Venues

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Celina L Szanto, Annelisa M Cornel, Sara M Tamminga, Eveline M Delemarre, Coco C H de Koning, Denise A M H van den Beemt, Ester Dunnebach, Michelle L Tas, Miranda P Dierselhuis, Lieve G A M Tytgat, Max M van Noesel, Kathelijne C J M Kraal, Jaap-Jan Boelens, Alwin D R Huitema, Stefan Nierkens
Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma. Cancers 13 (9) (2021)
Suzan Dijkstra, Kathelijne C J M Kraal, Godelieve A M Tytgat, Max M Van Noesel, Marc H W A Wijnen, Peter M Hoogerbrugge
Use of quality indicators in neuroblastoma treatment: A feasibility assessment. Pediatric blood & cancer 68 (9) (2020)
Michelle L Tas, Michelle Nagtegaal, Kathelijne C J M Kraal, Godelieve A M Tytgat, Nico G G M Abeling, Jan Koster, Saskia M F Pluijm, Christian Michel Zwaan, Bart de Keizer, Jan J Molenaar, Max M Van Noesel
Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease. Pediatric blood & cancer 67 (4) (2019)